The team here at Cannin.com has been investing in hemp stocks since 2017. Most hemp stock investors understand the astounding growth potential of the global hemp industry but don’t necessarily know the best hemp stocks to invest in. With so many investment options, how do you know which hemp stocks are the best bet for both short and long term gains? We’ve compiled a list of the top 3 hemp stocks to watch in 2022.
What Are Hemp Stocks?
Hemp stocks are stocks in companies involved in the hemp industry. Hemp is a variety of cannabis plant with many diverse applications spanning several industries. Cannabidiol (CBD) oil which is derived from hemp through processing continues to be widely acknowledged as a potent remedy against anxiety, depression and pain – among other maladies.
The CBD market is on track to explode in 2022 and in the coming years but industrial hemp but companies are poised to capitalize on industrial hemp opportunities as well. These companies are beginning to capitalize on the production of hemp for everything from textiles and construction materials – which are all both billion-dollar industries.
Related: 3 Best Hemp Stocks for 2021
While the upside to the industry is evident, quarterly results of the leading hemp industry players highlight that most of them are yet to turn a profit. Concerned investors have been offloading cannabis and hemp stocks over the last 18 months. COVID-19 concerns and rising volatility in the equity markets fueled 2020 sell-offs.
Which Cannabis & Hemp Stocks Have Recent IPOs?
Here’s an updated list of new cannabis and hemp companies with recent IPOs
| Company | Filing | Market | Description |
| AAA Medic Montreal | SEDAR | TSX-V | Quebec ACMPR Applicant |
| Blackshire Capital | SEDAR | CSE | Invests in Private Cannabis Companies |
| Breath of Life International | SEDAR | TSX | Israeli Licensed Medical Cannabis Producer |
| Clever Leaves | SEC | NASDAQ | Global Cannabis Operator |
| CWE European Holdings | SEDAR | TSXV | German Hemp Operator |
| Eden Empire | SEDAR | CSE | North American Integrated Cannabis Operator |
| Embark Health | SEDAR | TSX-V | Canadian Extraction LP |
| EMMAC Life Sciences | SEC | NASDAQ | European Cannabis Operator |
| Hemptown Organics | SEDAR | TSXV | CBD and CBG Production |
| HollyWeed North Cannabis | SEDAR | TSXV | Canadian LP Focused on Processing and Ancillary Solutions |
| Innovate Phytotechnologies | SEDAR | CSE | Canadian Hemp Services Provider and ACMPR Applicant |
| Lifted Innovations | SEDAR | CSE | Cannabis accessories e-commerce company in U.S. and Canada |
| Lobo Genetics | SEDAR | TSX-V | Genetics Testing for Cannabis Consumers |
| Company | Filing | Market | Description |
| Magical Brands | SEDAR | TSX-V | DIY Extraction |
| Merced Holdings | SEDAR | CSE | California Extraction |
| Merrco Payments | SEDAR | TSX-V | Canadian Payments Processor Focused on Cannabis |
| Molecular Science | SEDAR | TSX-V | Canadian Mobile Lab for Testing and Research |
| OG DNA Genetics | SEDAR | CSE | Seeds and Genetics |
| Province Brands | SEDAR | TSX-V | Canadian Developer of Cannabis Beverages |
| RYAH | SEDAR | CSE | U.S.-Based Data Aggregation and Technology |
| Santa Marta Life Sciences | SEDAR | TSX-V | Licensed Colombian Cannabis Producer |
| Southern Sun | SEDAR | TSX-V | Canadian Company Focused on Africa |
| Starling Brands | SEDAR | CSE | California Cannabis Operator |
| Subversive Real Estate Acquisition REIT | SEDAR | NEO | American Cannabis REIT |
| The Hacienda Company | SEDAR | CSE | California Cannabis Brand Owner |
| Theracann International Benchmark | SEDAR | TSX-V | Panama-Based Provider of Technology, Operations and Analytics |
| Varianz | SEDAR | TSX-V | Colombian Applicant |
| Xebra Brands | SEDAR | TSX-V | Latin American IP and Cultivation
|
What are the 3 Top Hemp Stocks for 2022?
Top Hemp Stock #1: GW Pharmaceuticals (GWPH)
[stock_market_widget type=”combo” symbol=”GWPH” template=”tablechart” color=”default” fields=”virtual.symbol,virtual.name,quote.regularMarketPrice,quote.regularMarketChange,quote.regularMarketChangePercent” chart=”line” range=”1y” interval=”1d” line-color=”rgb(14, 135, 28)”]
GW Pharma (NASDAQ: GWPH) is a biotech player and not a core cannabis company but it finds a mention in this list because of its flagship medicine, Epidiolex, which is derived from CBD. This medicine has had huge success in the treatment of epileptic seizures due to two rare syndromes in early childhood.
Epidolex has been well-received by the patients and the pharmaceutical industry. Epidiolex is the single-most factor driving the growth of GW Pharmaceuticals. The company is still unprofitable but one with immense growth potential.
GW Pharma has a robust balance sheet with a cash balance of more than $500 million. This depicts its inherent strength in being unperturbed in the face of the pandemic. It also highlights that the company has adequate finance to fuel further R&D and its growth opportunities.
Related: Global Cannabis Market To Hit $47 Billion By 2025: Marijuana Stocks to Watch
The COVID-19 crisis did not have a significant impact on most of the medical marijuana companies, because they were deemed as an essential service. The unique proposition of GW Pharma is its affordable drugs and limited competition in this segment. With more treatments and clinical trials underway, GW Pharmaceuticals is surely a smart stock pick in the medical cannabis category and we believe it’s one of the top 3 hemp stocks to watch in 2022.
Top Hemp Stock #2: Tilray (TLRY)
[stock_market_widget type=”combo” symbol=”TLRY” template=”tablechart” color=”default” fields=”virtual.symbol,virtual.name,quote.regularMarketPrice,quote.regularMarketChange,quote.regularMarketChangePercent” chart=”line” range=”1y” interval=”1d” line-color=”rgb(14, 135, 28)”]
With various hemp-products in its quiver, Tilray (NASDAQ: TLRY) is one of the most notable cannabis stocks which will make a mark in 2020 and beyond. After debuting in the U.S. markets at $17 per share, the company was quick enough to shoot past $300 per share, before plummeting to its record low of $2.43 in early 2020.
In a play to expand Tilray’s U.S. footprint, the company acquired Manitoba Harvest, which supplies over 70% of the hemp edibles nationwide. Its products are sold widely in about 13,500 retail shops in the U.S. including Costco and Walmart.
International expansion is the growth route for many cannabis companies and Tilray is no exception. The hemp stock exports its medicinal products to more than 13 international markets including Germany and Portugal and industry experts believe that this number is all set to double in the next few years. Because of this strong trajectory, we believe Tilray is one of the top 3 hemp stocks to watch in 2022.
Top Hemp Stock #3: HempFusion Wellness (CBDHF)
[stock_market_widget type=”combo” symbol=”CBDHF” template=”tablechart” color=”default” fields=”virtual.symbol,virtual.name,quote.regularMarketPrice,quote.regularMarketChange,quote.regularMarketChangePercent” chart=”line” range=”1y” interval=”1d” line-color=”rgb(14, 135, 28)”]
HempFusion, Inc. is a CBD health and wellness company with both a health and regulatory background. Cannin.com recommended HempFusion ahead of its IPO back January and the stock is up 300%.
HempFusion Wellness has over 46 SKUs with many more in development. The company’s CEO’s background as a product formator in the dietary supplement industry should prove to be invaluable.
Related: Best Hemp Stock to Watch 2021: Hemp, Inc.
Their strong regulatory experience also will come in handy with OTC listed products as they can make health claims – something all their competitors cannot do, and they understand how to play federally with their self-affirmed GRAS (generally regarded as safe) designations to the FDA. The market for HempFusion’s brand range of Probulin probiotics and digestive enzymes is estimated to be worth $76.7 billion by 2027 alone.
Scaling is the name of the game here as their direct competitors (Charlotte’s Web and CV Sciences) already have market caps over $400 million. If they can grow wisely and get their strongly branded products in more and more stores in the USA, Europe, and Latin America, then they should see revenues triple or more.
Keep a close eye on HempFusion and watch for prices to continue to climb. If you want to invest in the CBD industry, we’d strongly recommend considering a position in HempFusion (OTC:CBDHF). See our comprehensive fundamental analysis of HempFusion here.
Why cannin.com? Cannin.com has over two years of successful stock picks. In fact, 78% of our picks prove to be true within 30 days or less.
Top 3 Hemp Stocks to Watch in 2022
Cannin Investment Group: Your Hemp Stocks Experts
Cannin.com is your trusted resource for top hemp stocks. Our team of financial experts evaluates all emerging hemp stock investing opportunities. We aggregate hundreds of hours of market research to provide tips on the best hemp stocks for 2022.
Use Cannin as your resource for:
- Cannabis and hemp stocks & investing news
- Featured cannabis & hemp stocks analysis
- Comprehensive cannabis and hemp stock reports
Is it too late to invest in hemp stocks? No! This is the perfect time to invest.
Wall Street analysts expect the global cannabis industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in hemp stocks is now.
Are you interested in the best hemp stocks for 2022 like HempFusion, Inc., Charlotte’s Web, Canopy Growth, or Hemp Inc.?
Are you looking to buy stock in hemp companies or stock in cannabis companies in 2022? Interested in penny hemp stocks? Interested in leveraging the power of algorithmic stock trades to profit from hemp stocks? Looking for the best Canadian cannabis stocks? We can help.
Predict price movements of hemp stocks several hours in advance with our proprietary algorithmic stock trading software.
- +30% Gains in 2020
- +49.8% Gains in 2019
- Backtested since 2012
At Cannin, we’re so confident you’ll love our algotrading hemp stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.
Profit from the best hemp stocks – we’ll show you how at cannin.com.
